About 6 Trademarks found that are owned by Eirgen Pharma Ltd

pharmaceutical preparations for the treatment of diseases and disorders of the parathyroid and renal disease; pharmaceutical preparations for the treatment of hyperparathyroidism; pharmaceuticals for the treatment of secondary hyperparathyroidism; pharmaceutical preparations for the treatment of vitamin D deficiency; nutritional supplements, vitamin supplements

Pharmaceutical [ and veterinary ] preparations for the treatment of musculoskeletal, renal, endocrinal, and neurological diseases; Pharmaceutical preparations, namely, phosphate binders for use in the treatment of hyperphosphataemia; Magnesium iron hydroxy carbonate and hydrotalcite for medical, pharmaceutical [ and veterinary ] preparations for use in renal dialysis and in the treatment of renal diseases and kidney ailments; pharmaceutical [ and veterinary ] preparations for use in treating bone, muscle and kidney diseases and disorders; pharmaceutical [ and veterinary ] preparations for controlling phosphorous metabolism and calcium metabolism

Medical information; Providing medical information; Providing medical information to health care providers in the form of reports in the field of chronic kidney disease

The mark consists of a pair of yellow and purple curved segments that partially overlap, with the overlapped section appearing in the color dark blue.

The mark consists of a pair of yellow and purple curved segments that partially overlap, with the overlapped section appearing in the color dark blue.

prescription pharmaceutical products, namely, calcifediol for treating symptoms from infection with the SARS-CoV-2 virus (COVID-19)